Vera finally notches a win for Merck KGaA castoff in autoimmune kidney disease

Vera finally notches a win for Merck KGaA castoff in autoimmune kidney disease

Source: 
Fierce Biotech
snippet: 

Merck KGaA eventually abandoned atacicept after trying again and again in multiple autoimmune disorders. Now, Vera Therapeutics has succeeded where the Big Pharma failed.